2018Biomedical Journal of Scientific & Technical ResearchOpen access

Immunculus as an Approach for the Evaluation of Multiple Sclerosis: A Case Report

Mir Hadi Jazayeri

Open full text 0 citations

Abstract

Fingolimod is the first agent used for the treatment of relapsing-remitting multiple sclerosis. Here we report a case, who was diagnosed with multiple sclerosis, after receiving fingolimod treatment feels well except mild tingling in his hands and feet. >

Open-access reader

About this research paper

What this paper is about

Fingolimod is the first agent used for the treatment of relapsing-remitting multiple sclerosis. Here we report a case, who was diagnosed with multiple sclerosis, after receiving fingolimod treatment feels well except mild tingling in his hands and feet. >

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Fingolimod is the first agent used for the treatment of relapsing-remitting multiple sclerosis. Here we report a case, who was diagnosed with multiple sclerosis, after receiving fingolimod treatment feels well except mild tingling in his hands and feet. >

Key concepts: Fingolimod, Multiple sclerosis, Relapsing remitting, Medicine, Tingling, Dermatology, Surgery, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Immunculus as an Approach for the Evaluation of Multiple Sclerosis: A Case Report — Research Paper | ScholarLens